Charles E. Jackson
Bruker (United States)(US)University of Michigan–Ann Arbor(US)Bruker (Switzerland)(CH)
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Parathyroid Disorders and Treatments, Thyroid Cancer Diagnosis and Treatment, Muscle Physiology and Disorders, Genetic factors in colorectal cancer
Most-Cited Works
- → Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1(1994)1,489 cited
- → Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2(1996)1,120 cited
- → Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A(1995)991 cited
- → HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome(2002)745 cited
- → Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC(1994)651 cited
- Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.(1996)
- → Single missense mutation in the tyrosine kinasecatalytic domain of the RET protooncogene is associated with multiple endocrineneoplasia type 2B.